Literature DB >> 34844040

High-frequency irreversible electroporation brain tumor ablation: exploring the dynamics of cell death and recovery.

Kelsey R Murphy1, Kenneth N Aycock2, Alayna N Hay3, John H Rossmeisl4, Rafael V Davalos5, Nikolaos G Dervisis6.   

Abstract

Improved therapeutics for malignant brain tumors are urgently needed. High-frequency irreversible electroporation (H-FIRE) is a minimally invasive, nonthermal tissue ablation technique, which utilizes high-frequency, bipolar electric pulses to precisely kill tumor cells. The mechanisms of H-FIRE-induced tumor cell death and potential for cellular recovery are incompletely characterized. We hypothesized that tumor cells treated with specific H-FIRE electric field doses can survive and retain proliferative capacity. F98 glioma and LL/2 Lewis lung carcinoma cell suspensions were treated with H-FIRE to model primary and metastatic brain cancer, respectively. Cell membrane permeability, apoptosis, metabolic viability, and proliferative capacity were temporally measured using exclusion dyes, condensed chromatin staining, WST-8 fluorescence, and clonogenic assays, respectively. Both tumor cell lines exhibited dose-dependent permeabilization, with 1,500 V/cm permitting and 3,000 V/cm inhibiting membrane recovery 24 h post-treatment. Cells treated with 1,500 V/cm demonstrated significant and progressive recovery of apoptosis and metabolic activity, in contrast to cells treated with higher H-FIRE doses. Cancer cells treated with recovery-permitting doses of H-FIRE maintained while those treated with recovery-inhibiting doses lost proliferative capacity. Taken together, our data suggest that H-FIRE induces reversible and irreversible cellular damage in a dose-dependent manner, and the presence of dose-dependent recovery mechanisms permits tumor cell proliferation.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Brain cancer; Cell death; High-frequency irreversible electroporation; Proliferation; Recovery

Mesh:

Year:  2021        PMID: 34844040      PMCID: PMC8792323          DOI: 10.1016/j.bioelechem.2021.108001

Source DB:  PubMed          Journal:  Bioelectrochemistry        ISSN: 1567-5394            Impact factor:   5.373


  68 in total

1.  Treatment of a single brain metastasis: the role of radiation following surgical resection.

Authors:  A P Mintz; J G Cairncross
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

2.  Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.

Authors:  John H Rossmeisl; Paulo A Garcia; Theresa E Pancotto; John L Robertson; Natalia Henao-Guerrero; Robert E Neal; Thomas L Ellis; Rafael V Davalos
Journal:  J Neurosurg       Date:  2015-07-03       Impact factor: 5.115

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

Review 4.  The diagnosis and management of brain metastases.

Authors:  M J van den Bent
Journal:  Curr Opin Neurol       Date:  2001-12       Impact factor: 5.710

5.  Non-small-cell Lung Cancer With Brain Metastasis at Presentation.

Authors:  Saiama N Waqar; Pamela P Samson; Cliff G Robinson; Jeffrey Bradley; Siddhartha Devarakonda; Lingling Du; Ramaswamy Govindan; Feng Gao; Varun Puri; Daniel Morgensztern
Journal:  Clin Lung Cancer       Date:  2018-03-09       Impact factor: 4.785

6.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.

Authors:  Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

7.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

Authors:  Leo J Schouten; Joost Rutten; Hans A M Huveneers; Albert Twijnstra
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

9.  Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses.

Authors:  Suyashree P Bhonsle; Christopher B Arena; Daniel C Sweeney; Rafael V Davalos
Journal:  Biomed Eng Online       Date:  2015-08-27       Impact factor: 2.819

10.  High-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model.

Authors:  Eduardo L Latouche; Christopher B Arena; Jill W Ivey; Paulo A Garcia; Theresa E Pancotto; Noah Pavlisko; Scott S Verbridge; Rafael V Davalos; John H Rossmeisl
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.